Drugs / BCT194
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01539915 | Apr → Nov 2007 | psoriasis | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT00417820 | Nov 2006 → Nov 2007 | psoriasis | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCT194 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00417820 ↗ |
| Route | Topical | “single topical administration of BCT194” NCT00417820 ↗ |